ID

14481

Beschreibung

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00895895

Link

https://clinicaltrials.gov/show/NCT00895895

Stichworte

  1. 17.04.16 17.04.16 -
Hochgeladen am

17. April 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Alzheimer Disease NCT00895895

Eligibility Alzheimer Disease NCT00895895

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of probable alzheimer disease according to the national institute of neurological and communicative disorders and stroke-alzheimer's diseases and related disorders association (nincds-adrda) criteria.
Beschreibung

alzheimers disease; NINCDS-ADRDA Criteria

Datentyp

boolean

Alias
UMLS CUI [1]
C0002395
UMLS CUI [2]
C2828081
mini-mental state examination (mmse) score of 12 to 24 at screening
Beschreibung

mini-mental state examination

Datentyp

boolean

Alias
UMLS CUI [1]
C0451306
rosen modified hachinski ischemic score < or equal to 4 at screening.
Beschreibung

Modified Hachinski Ischemic Scale

Datentyp

boolean

Alias
UMLS CUI [1]
C3826978
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
relevant neurologic disease other than alzheimer disease that may affect cognition or ability to complete the study.
Beschreibung

neurologic disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0027765
current major depressive disorder or other current major psychiatric disorder.
Beschreibung

depressive disorder; psychiatric disorder

Datentyp

boolean

Alias
UMLS CUI [1]
C0011581
UMLS CUI [2]
C0004936
history of clinically evident stroke or clinically important carotid or vertebrobasilar stenosis or plaque.
Beschreibung

stroke; Carotid Stenosis; vertebrobasilar stenosis; plaque

Datentyp

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0007282
UMLS CUI [3]
C0149810
UMLS CUI [4]
C0332461
use of prescription or nonprescription medications for cognitive enhancement (including memantine, ginkgo biloba, huperzine a, and cholinesterase inhibitors) within 3 months before the baseline visit.
Beschreibung

memantine; Ginkgo biloba; huperzine a; cholinesterase inhibitors

Datentyp

boolean

Alias
UMLS CUI [1]
C0025242
UMLS CUI [2]
C0330206
UMLS CUI [3]
C0063033
UMLS CUI [4]
C0008425

Ähnliche Modelle

Eligibility Alzheimer Disease NCT00895895

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
alzheimers disease; NINCDS-ADRDA Criteria
Item
diagnosis of probable alzheimer disease according to the national institute of neurological and communicative disorders and stroke-alzheimer's diseases and related disorders association (nincds-adrda) criteria.
boolean
C0002395 (UMLS CUI [1])
C2828081 (UMLS CUI [2])
mini-mental state examination
Item
mini-mental state examination (mmse) score of 12 to 24 at screening
boolean
C0451306 (UMLS CUI [1])
Modified Hachinski Ischemic Scale
Item
rosen modified hachinski ischemic score < or equal to 4 at screening.
boolean
C3826978 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
neurologic disease
Item
relevant neurologic disease other than alzheimer disease that may affect cognition or ability to complete the study.
boolean
C0027765 (UMLS CUI [1])
depressive disorder; psychiatric disorder
Item
current major depressive disorder or other current major psychiatric disorder.
boolean
C0011581 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
stroke; Carotid Stenosis; vertebrobasilar stenosis; plaque
Item
history of clinically evident stroke or clinically important carotid or vertebrobasilar stenosis or plaque.
boolean
C0038454 (UMLS CUI [1])
C0007282 (UMLS CUI [2])
C0149810 (UMLS CUI [3])
C0332461 (UMLS CUI [4])
memantine; Ginkgo biloba; huperzine a; cholinesterase inhibitors
Item
use of prescription or nonprescription medications for cognitive enhancement (including memantine, ginkgo biloba, huperzine a, and cholinesterase inhibitors) within 3 months before the baseline visit.
boolean
C0025242 (UMLS CUI [1])
C0330206 (UMLS CUI [2])
C0063033 (UMLS CUI [3])
C0008425 (UMLS CUI [4])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video